Test development and validation (COVID-19 and monkeypox)

Sept. 23, 2022
Virtual town hall series.

The U.S. Food and Drug Administration (FDA) will continue hosting a virtual Town Hall series for SARS-CoV-2 (COVID-19) test developers and will now also include information and answer questions about monkeypox test development. For each Town Hall, the FDA will indicate whether the session will address COVID-19, monkeypox, or both.

Registration is not necessary.

There will be an opportunity to ask questions live on the call, and questions may also be submitted in advance by emailing [email protected].

  • Please submit questions by Monday, September 26, 12 p.m. ET before the Wednesday virtual Town Hall.
  • In the subject line of the email, type type “Questions for the Virtual Town Hall Series - Test Development and Validation During Public Health Emergencies” and clearly indicate whether your question is about COVID-19 or monkeypox.

Save the Date:

The FDA will hold a virtual Town Hall for test developers from 12:05 p.m.-1 p.m. ET on:

  • September 28: Town Hall #93 (COVID-19 and Monkeypox)
  • October 5: Town Hall #94 (Monkeypox)
  • October 12: Town Hall #95 (Monkeypox)

FDA release